Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-211-0 | CAS number: 117-81-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 1986 - May 1986
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP study realised according to the OECD guideline 412, with acceptable restrictions.
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Di(2-ethylhexyl) phthalate (DEHP): A short-term repeated inhalation toxicity study including fertility assessment.
- Author:
- Klimisch HJ, Gamer AO, Hellwig J
- Year:
- 1 992
- Bibliographic source:
- Fd. Chem. Toxic. 30, 915-919
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Bis(2-ethylhexyl) phthalate
- EC Number:
- 204-211-0
- EC Name:
- Bis(2-ethylhexyl) phthalate
- Cas Number:
- 117-81-7
- Molecular formula:
- C24H38O4
- IUPAC Name:
- 1,2-bis(2-ethylhexyl) benzene-1,2-dicarboxylate
- Details on test material:
- DEHP with a purity of 99.7%, determined by gas chromatography
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF Wistar/Chbb: Thom rats (Dr Thomae GmbH, Biberach, Germany)
- Age at study initiation: 9 wk old
- Weight at study initiation: 226 g (male) and 155 g (female)
- Fasting period before study: no
- Housing: maintained in individual Makrolon/wire cages in air-conditioned rooms
- Diet (e.g. ad libitum): ad libitum (Kliba 24-343-4 pellets)
- Water (e.g. ad libitum): ad libitum tap water
- Acclimation period: 1wk
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- Head-nose exposure systems, each with a volume of 90 l and providing for the simultaneous exposure of 60 animals (INA 60, glass-steel construction, BASF AG) were used. The animals were restrained in glass tubes with their snouts projecting into the inhalation system. An aerosol was generated for each group with a two-component atomizer (Schlick 970, Schlick Coburg, Germany) supplied with the test substance by a metering pump (INFU 362, Indigel, Switzerland) and 1500 l/hr compressed air. After passing through a droplet separator, the aerosol was mixed with humidified supply air to form the final inhalation atmosphere that was fed into the inhalation system. The exhaust air system connected to the inhalation system was set to a slightly lower exhaust flow, compared with the supply flow, to ensure a positive pressure in the system and to avoid dilution of the aerosol in the animals' breathing zones. The air exchange rate was about 36-40 times per hr in the treated groups and 58 times per hr in the air control. The air-flows, relative humidity and temperature in the inhalation system were measured and recorded several times during each exposure.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Hourly samples of the inhalation atmospheres were drawn from the breathing zone of the animals and absorbed in xylene through a glass tube filled with quartz wool and two fritted glass flasks. The samples were analyzed by gas chromatography .
Particle size measurement was performed with a cascade impactor (Anderson Stack Sampler Mark III) once during the study for each concentration. The deposits on the individual metal collecting disks were analysed by gas chromatography and the particle size distribution was calculated. - Duration of treatment / exposure:
- 6h
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
1.0, 0.05 and 0.01 mg/l
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
230, 11 and 2.3 mg/kg for males and 360, 18 and 3.6 mg/kg
Basis:
other: estimated daily intake
- No. of animals per sex per dose:
- main groups (10 males and 10 females),
satellite group I (2 males and 2 females) for the investigations of peroxisome prolifération, fertility (males) and reversibility of effects.
satellite group II (15 males and 2-5 females) for evaluation of male fertility - Control animals:
- yes, sham-exposed
- Details on study design:
- The animals of the main group and satellite group I were killed immediately after the exposure period, the former for haematology, clinical chemistry and pathology, the latter for a special examination of liver pathology.
Each male animal of satellite group II (15 per group) was mated overnight 2 and 6 wk after the end of exposure, with two non-treated mature female virgin rats of the same strain, until the vaginal smear was sperm positive; the maximum mating interval was 10 days. Two mating periods were chosen bearing in mind the duration of the spermatogenic cycle in the rat. 8 wk after the end of exposure all the animals of satellite group II (15 males and five females in groups 0 and 3, and 15 males and 2 females in groups 1 and 2) were killed and examined as detailed above to check for the reversibility or progression of any treatment effects. - Positive control:
- none
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: before during and after exposure daily
BODY WEIGHT: Yes
- Time schedule for examinations: twice weekly
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- When / How many animals: in all of the animals from the main groups, directly after the end of the exposure period and from five animals of each sex, in the control and high-dose groups of satellite group II, at the end of the 8-wk post-exposure period
CLINICAL CHEMISTRY: Yes / No / No data
- Animals fasted: No data
- When / How many animals: in all of the animals from the main groups, directly after the end of the exposure period and from five animals of each sex, in the control and high-dose groups of satellite group II, at the end of the 8-wk post-exposure period
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
Routine macroscopic and microscopic pathological examinations of all animals of the main groups and some of the satellite animals was carried out. Body, liver, kidney, testes, adrenal, heart, lung and brain weights were determined. Light microscopic examinations of the lung, trachea, nasal cavity, liner, kidney, spleen, adrenals, heart, brain, spinal cord, sciatic nerve, gastrocnemius muscle, testes, epididymis, prostate, seminal vesicle and all organs with gross findings, were carried out, mainly on slides stained with haemotoxylin and eosin. on all animals of groups 0 and 3 in the main group. In the other groups only selected organs were investigated. Toluidine blueisafranin-stained semi-thin sections were prepared from Epon-embedded liver samples of perfusion-fixed animals (two male and two female animals per group) for detailed light microscopic examination and ultrathin sections were prepared for electron microscopy. - Other examinations:
- Fertility
The interval from the beginning of the mating period to the first sperm-positive vaginal smear was recorded. Female animals were killed 14 days after either the detection of sperm or the last day of the mating period. The corpora lutea were counted and the uterine contents were examined for live or dead implantations and resorptions. The male and female fertility indices as well as pre- and post-implantation losses were calculated. - Statistics:
- Body weights, and haematological and clinicochemical parameters were evaluated by analysis of variance (ANOVA) followed by Dunnett's test. For post-mortem body- and organ weight analysis a Williams t-test was used. The fertility assessment data were analysed wither by Fisher's exact test or by the Krauth test.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- effects observed, treatment-related
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- CLINICAL SIGNS AND MORTALITY
No mortalities or clinical symptoms were observed during the study.
BODY WEIGHT AND WEIGHT GAIN
Body weights and body weight changes (growth) were similar in all groups.
HAEMATOLOGY
No significant changes could be detected in the following parameters: a number of red and white blood tells, platelets and reticulocytes, haemoglobin concentration, haematocrit, mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration and differential blood count. The thromboplastin time was not affected.
CLINICAL CHEMISTRY
No elevation in plasma concentrations of the enzymes, alanine aminotransferase, aspartate aminci-transférase or alkaline phosphatase, occurred. There were no significant changes in the plasma concentrations of sodium, potassium, calcium, chloride, urea, creatinine. glucose, total bilirubin, triglycerides, cholesterol, total protein and globuline. An increase in plasma albumin concentration in the animals of the highest concentration group was observed, and this was reversed in male but not female animals during the post-exposure period. Additionally, the inorganic phosphate was increased in the male rats at this concentration.
ORGAN WEIGHTS
The absolute liver weight of female animals and the relative liver weights of male and female animals of the highest concentration group were elevated at the end of the exposure period. Furthermore, the relative lung weight of male animals in this group was significantly increased. These findings were reversed during the post-exposure period (satellite groups).
GROSS PATHOLOGY
No substance-related gross lesions could be detected.
HISTOPATHOLOGY: NON-NEOPLASTIC
A few sporadic changes that were not attributable to the treatment were seen in the trachea, urinary tract, male reproductive organs and spleen. Semiquantitative grading of foam-cell content and alveolar septal thickening in the lungs revealed a slight increase in these findings in the main group at the highest concentration, which correlated well with the increased organ weight and was reversed within the post-exposure period. No light-microscopic changes (in routine histology and semi-thin sections), corresponding to the increased liver weights at the highest concentration were observed. No testicular toxicity was detected.
No substructural changes attributable to the treatment were seen by electron microscopy; in particular, no prolifération of peroxisomes occurred.
OTHER FINDINGS: FERTILITY:
There were no indications of substance-related effects on male reproductive function.
Effect levels
- Dose descriptor:
- NOAEC
- Effect level:
- 50 mg/m³ air
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The analytical concentrations matched well with the target concentrations. The mass median aerodynamic diameter of 1.2µm or below insured a readily inhaled aerosol.
Applicant's summary and conclusion
- Executive summary:
In a repeated dose toxicity study realised according to the OECD guideline 412, Wistar rats (10 males and females per group in the main dose group; 2 males and females per group in satellite group I, 15 males and 2-5 females per group in satellite group II; an equal number of control rats in each group; 9 weeks old at the beginning of exposure) were exposed in head-nose inhalation systems to DEHP (99.7% pure) aerosols of respirable particle size (mass median aerodynamic diameter 1.2 ± 2.9-9.5 μm) or air (control). Exposure duration was 6 hours per day, 5 days per week for 4 weeks at 0, 0.01, 0.05, or 1.0 mg/litre (0, 10, 50, or 1,000 mg/m3). The animals of the main dose group were sacrificed at the end of the exposure period. Before sacrifice, male rats from satellite group II had a recovery period of 2 or 6 weeks after termination of exposure. Livers of animals from satellite groups I and II were examined by light and electron microscopy. No animals died during the study. Clinical examination and blood chemistry parameters did not reveal treatment-related effects. Body weights of treated rats and controls were similar. In the highest dose group, a significant increase in relative lung weights was seen in male rats. This was accompanied by foam cell proliferation and thickening of the alveolar septi. Absolute liver weights (females) and relative liver weights (both sexes) were slightly but significantly increased but there were no corresponding histological findings. All these effects were reversible within the post-exposure observation period. No testicular toxicity was detected histologically. Electron microscopical examination of liver samples from all three concentration groups and controls at the end of exposure and after the post-exposure period did not reveal clear ultrastructural changes in hepatocytes that could be attributed to the exposure or to peroxisome proliferation.
The NOAEL in this study is 50 mg/m3.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.